BioAtla, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
Mailing Address 11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
Phone 858-558-0708
Fiscal Year End 1231
EIN 851922320
Financial Overview
FY2024
$52.42M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 6, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 8-K Current report of material events | December 31, 2025 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | December 5, 2025 | View on SEC |
| 4 Insider stock transaction report | December 1, 2025 | View on SEC |
| 4 Insider stock transaction report | December 1, 2025 | View on SEC |
Material Events
8-K Financial Distress February 9, 2026
High Impact
- BioAtla (BCAB) secured a temporary stay, allowing its stock to continue trading on Nasdaq despite a delisting notice.
- The company is actively appealing Nasdaq's delisting decision, challenging rule interpretations and alleged policy changes.
8-K Financial Distress February 6, 2026
High Impact
- Nasdaq will suspend trading of BioAtla, Inc.'s common stock due to non-compliance.
- The delisting is primarily due to failure to meet the minimum bid price ($1.00) and stockholders' equity ($2.5 million) requirements.
8-K Financial Distress December 30, 2025
High Impact
- BioAtla shareholders approved a plan to issue new stock for financing purposes.
- Shareholders did not approve a proposal for a reverse stock split.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.